Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 31-Jan-24 7:58 PM View:  | Omniab, Inc. (OABI) | 30-Jan-24 | Option Exercise | 13,173 | -- | -- | < 1% 2.34M to 2.35M | |
| 30-Oct-23 4:47 PM View: | Techne Corp. (TECH) | 26-Oct-23 | Grant | 1,625 | -- | -- | 5% 34.98K to 36.61K | |
| 25-May-23 4:45 PM View: | Omniab, Inc. (OABI) | 23-May-23 | Option Exercise | 9,000 | $3.68 | $33,120.00 | < 1% 2.46M to 2.47M | |
| 25-May-23 4:45 PM View: | Omniab, Inc. (OABI) | 23-May-23 | Option Sale | 9,000 | $4.05 | $36,450.00 | (< 1%) 2.47M to 2.46M | |
| 23-May-23 4:12 PM View: | Omniab, Inc. (OABI) | 19-May-23 | Option Exercise | 1,000 | $3.68 | $3,680.00 | < 1% 2.46M to 2.46M | |
| 23-May-23 4:12 PM View: | Omniab, Inc. (OABI) | 19-May-23 | Option Sale | 1,000 | $4.05 | $4,050.00 | (< 1%) 2.46M to 2.46M | |
| 19-May-23 5:03 PM View: | Omniab, Inc. (OABI) | 18-May-23 | Option Exercise | 50,000 | $3.68 | $184,000.00 | 2% 2.46M to 2.51M | |
| 19-May-23 5:03 PM View: | Omniab, Inc. (OABI) | 18-May-23 | Option Sale | 50,000 | $3.89 | $194,500.00 | (2%) 2.51M to 2.46M | |
| 02-May-23 10:00 PM View: | Techne Corp. (TECH) | 28-Apr-23 | Payment of Exercise | 4,377 | $79.88 | $349,635.00 | (11%) 39.36K to 34.98K | |
| 02-May-23 10:00 PM View: | Techne Corp. (TECH) | 28-Apr-23 | Option Exercise | 16,000 | $21.85 | $349,600.00 | 68% 23.36K to 39.36K | |
| 01-Feb-23 2:29 PM View: | Omniab, Inc. (OABI) | 30-Jan-23 | Grant | 39,517 | -- | -- | 2% 2.42M to 2.46M | |
| 27-Jun-23 6:33 PM View: | Omniab, Inc. (OABI) | 04-Jan-23 | Payment of Exercise | 57,803 | $3.23 | $186,704.00 | 3% 2.28M to 2.34M | |
| 30-Dec-22 5:00 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 28-Dec-22 | Payment of Exercise | 5,289 | $66.29 | $350,608.00 | (1%) 422.98K to 417.69K | |
| 27-Jun-23 6:33 PM View: | Omniab, Inc. (OABI) | 28-Dec-22 | Payment of Exercise | 25,914 | $3.66 | $94,845.20 | 1% 2.37M to 2.4M | |
| 20-Dec-22 6:36 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 16-Dec-22 | Sale (Planned) | 10,000 | $61.87 | $618,657.00 | (2%) 432.98K to 422.98K | |
| 14-Dec-22 5:00 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 12-Dec-22 | Disposition | 3,944 | $64.80 | $255,571.00 | (< 1%) 436.93K to 432.98K | |
| 14-Dec-22 5:00 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 12-Dec-22 | Option Exercise | 20,000 | $12.78 | $255,600.00 | 5% 416.93K to 436.93K | |
| 01-Dec-22 9:42 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 30-Nov-22 | Payment of Exercise | 9,803 | $72.90 | $714,639.00 | (2%) 426.73K to 416.93K | |
| 21-Nov-22 7:04 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 18-Nov-22 | Option Exercise | 10,000 | $12.78 | $127,800.00 | 2% 416.73K to 426.73K | |
| 21-Nov-22 7:04 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 17-Nov-22 | Planned Option Sale | 10,000 | $78.32 | $783,173.00 | (2%) 426.73K to 416.73K | |
| 03-Nov-22 9:15 PM View: | Omniab, Inc. (OABI) | 02-Nov-22 | Option Exercise | 246,648 | $2.52 | $621,553.00 | 11% 2.18M to 2.42M | |
| 03-Nov-22 9:15 PM View: | Omniab, Inc. (OABI) | 01-Nov-22 | Grant | 2,176,520 | -- | -- | 100% 0 to 2.18M | |
| 03-Nov-22 9:05 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 01-Nov-22 | Grant | 45,922 | -- | -- | 12% 378.81K to 424.73K | |
| 31-Oct-22 5:24 PM View: | Techne Corp. (TECH) | 27-Oct-22 | Grant | 338 | -- | -- | 6% 5.5K to 5.84K | |
| 16-Sep-22 7:49 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 16-Sep-22 | Sale | 3,000 | $89.35 | $268,050.00 | (< 1%) 367.18K to 364.18K | |
| 16-Sep-22 7:49 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 15-Sep-22 | Sale | 2,000 | $90.00 | $180,000.00 | (< 1%) 369.18K to 367.18K | |
| 12-Aug-22 4:02 PM View: | Techne Corp. (TECH) | 11-Aug-22 | Option Sale | 512 | $385.39 | $197,322.00 | (9%) 6.01K to 5.5K | |
| 12-Aug-22 4:02 PM View: | Techne Corp. (TECH) | 10-Aug-22 | Option Exercise | 3,400 | $66.90 | $227,460.00 | 74% 4.61K to 8.01K | |
| 12-Aug-22 4:02 PM View: | Techne Corp. (TECH) | 10-Aug-22 | Option Sale | 1,992 | $377.11 | $751,194.00 | (25%) 8.01K to 6.01K | |
| 06-Jul-22 8:00 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 30-Jun-22 | Acquisition (other) | 164 | $75.84 | $12,437.30 | < 1% 369.02K to 369.18K | |
| 14-Jun-22 5:55 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 10-Jun-22 | Grant | 20,423 | -- | -- | 6% 348.59K to 369.02K | |
| 09-Jun-22 5:07 PM View: | Techne Corp. (TECH) | 08-Jun-22 | Option Exercise | 600 | $66.90 | $40,140.00 | 13% 4.61K to 5.21K | |
| 09-Jun-22 5:07 PM View: | Techne Corp. (TECH) | 08-Jun-22 | Option Sale | 600 | $366.09 | $219,654.00 | (12%) 5.21K to 4.61K | |
| 09-Jun-22 5:07 PM View: | Techne Corp. (TECH) | 07-Jun-22 | Option Exercise | 1,000 | $66.90 | $66,900.00 | 22% 4.61K to 5.61K | |
| 09-Jun-22 5:07 PM View: | Techne Corp. (TECH) | 07-Jun-22 | Option Sale | 1,000 | $364.31 | $364,310.00 | (18%) 5.61K to 4.61K | |
| 10-May-22 5:33 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 09-May-22 | Option Exercise | 8,000 | $21.92 | $175,360.00 | 2% 340.59K to 348.59K | |
| 16-Feb-22 8:23 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 15-Feb-22 | Payment of Exercise | 5,923 | $123.68 | $732,557.00 | (2%) 346.52K to 340.59K | |
| 28-Jan-22 8:42 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 26-Jan-22 | Grant | 23,166 | -- | -- | 7% 335.1K to 358.26K | |
| 28-Jan-22 8:42 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 26-Jan-22 | Payment of Exercise | 9,243 | $113.68 | $1,050,740.00 | (3%) 358.26K to 349.02K | |
| 07-Feb-22 10:00 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 15-Nov-21 | Gift | 2,502 | -- | -- | (< 1%) 335.1K to 332.59K | |
| 12-Nov-21 7:31 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 12-Nov-21 | Market Sale | 3,000 | $160.50 | $481,500.00 | (< 1%) 338.1K to 335.1K | (1%) |
| 01-Nov-21 4:41 PM View: | Techne Corp. (TECH) | 28-Oct-21 | Grant | 194 | -- | -- | 4% 4.41K to 4.61K | |
| 18-Feb-21 6:27 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 15-Feb-21 | Payment of Exercise | 5,212 | $172.46 | $898,862.00 | (2%) 343.06K to 337.85K | 25% |
| 09-Feb-21 6:08 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 05-Feb-21 | Payment of Exercise | 2,970 | $203.03 | $602,999.00 | (< 1%) 400.7K to 397.73K | 36% |
| 09-Feb-21 6:08 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 05-Feb-21 | Option Exercise | 60,000 | $10.05 | $603,000.00 | 21% 286.03K to 346.03K | |
| 09-Feb-21 6:08 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 05-Feb-21 | Option Exercise | 54,666 | $14.47 | $791,017.00 | 16% 346.03K to 400.7K | |
| 09-Feb-21 6:08 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 05-Feb-21 | Market Option Sale | 54,666 | $203.40 | $11,119,200.00 | (14%) 397.73K to 343.06K | 36% |
| 05-Feb-21 5:02 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 03-Feb-21 | Grant | 12,608 | -- | -- | 5% 273.42K to 286.03K | |
| 27-Jan-21 7:04 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 27-Jan-21 | Option Exercise | 30,000 | $21.92 | $657,600.00 | 12% 243.42K to 273.42K | |
| 27-Jan-21 7:04 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 27-Jan-21 | Option Exercise | 40,000 | $14.47 | $578,800.00 | 15% 273.42K to 313.42K |